0.5856
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
What drives PAVmed Inc. stock pricePhenomenal capital appreciation - PrintWeekIndia
What analysts say about PAVmed Inc. stockSuperior stock growth - PrintWeekIndia
PAVmed Inc. Stock Analysis and ForecastExplosive trading growth - PrintWeekIndia
Is PAVmed Inc. a good long term investmentDynamic profit opportunities - jammulinksnews.com
Why PAVmed Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - beatles.ru
Lucid says meeting scheduled to determine Medicare coverage for cancer test - MSN
Lucid says AdCom meeting set to determine cancer test coverage - Seeking Alpha
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - StreetInsider
How PAVmed Inc. stock performs during market volatilityFree Low-Risk Investment Plans - Newser
What makes PAVmed Inc. stock price move sharplyLow Volatility High Yield Stocks - Newser
PAVmed's Veris Health Secures $2.5M at $35M Valuation to Advance Revolutionary Cancer Monitor - Stock Titan
PAVmed’s Veris Health Completes $2.5M Offering - TipRanks
PAVmed Holds Annual Stockholders Meeting, Approves Key Proposals - TipRanks
Leading California Hospital Network Launches Revolutionary 3-Minute Cancer Detection Test from Lucid Diagnostics - Stock Titan
Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test - Finansavisen
PAVmed (NASDAQ:PAVM) Given New $19.00 Price Target at Ascendiant Capital Markets - Defense World
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know - MSN
PAVM: Ascendiant Capital Maintains Buy Rating but Lowers Price Target | PAVM Stock News - GuruFocus
PAVmed subsidiary Veris Health partners with Ohio State University cancer center - Yahoo Finance
Pavmed's Veris Health Signs Long-Term Partnership Deal With Ohio State University Hospital - marketscreener.com
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnersh - GuruFocus
PAVM Subsidiary Veris Health Partners with OSUCCC -- James for Cancer Care Innovations | PAVM Stock News - GuruFocus
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer CenterJames Cancer Hospital and Solove Research Institute | PAVM Sto - GuruFocus
Lucid Diagnostics joins Russell 2000 and 3000 indexes - Mugglehead Magazine
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - The Malaysian Reserve
Lucid Diagnostics to join Russell 2000 and Russell 3000 indexes - Investing.com
Lucid Diagnostics to join Russell 2000 and Russell 3000 indexes By Investing.com - Investing.com UK
Lucid Diagnostics Joins Elite Russell Indexes, Opens Door to $10.6T Investment Pool - Stock Titan
PAVmed Inc. (NASDAQ:PAVM) Q1 2025 Earnings Call Transcript - Insider Monkey
PAVmed Inc (PAVM) Q1 2025 Earnings Call Highlights: Strategic Expansion and Financial Fortification - Yahoo Finance
Pavmed Inc. Reports Turnaround with Strong Q1 Earnings - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):